News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,691 Results
Type
Article (41062)
Company Profile (275)
Press Release (666354)
Multimedia
Podcasts (58)
Webinars (12)
Section
Business (206400)
Career Advice (2012)
Deals (35743)
Drug Delivery (97)
Drug Development (82389)
Employer Resources (172)
FDA (16350)
Job Trends (15018)
News (349135)
Policy (32805)
Tag
Academia (2594)
Accelerated approval (5)
Adcomms (23)
Allergies (86)
Alliances (50251)
ALS (94)
Alzheimer's disease (1389)
Antibody-drug conjugate (ADC) (149)
Approvals (16343)
Artificial intelligence (272)
Autoimmune disease (23)
Automation (16)
Bankruptcy (361)
Best Places to Work (11773)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (199)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (298)
Cancer (2403)
Cardiovascular disease (179)
Career advice (1681)
Career pathing (30)
CAR-T (162)
Cell therapy (449)
Cervical cancer (21)
Clinical research (67132)
Collaboration (875)
Company closure (2)
Compensation (568)
Complete response letters (20)
COVID-19 (2603)
CRISPR (43)
C-suite (259)
Cystic fibrosis (101)
Data (2320)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (275)
Diagnostics (6456)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87539)
Editorial (41)
Employer branding (21)
Employer resources (146)
Events (114529)
Executive appointments (746)
FDA (17726)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (112)
Generative AI (23)
Gene therapy (314)
GLP-1 (726)
Government (4456)
Grass and pollen (4)
Guidances (151)
Healthcare (19058)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (127)
Indications (29)
Infectious disease (2749)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (312)
IPO (16652)
IRA (41)
Job creations (3660)
Job search strategy (1426)
Kidney cancer (11)
Labor market (43)
Layoffs (493)
Leadership (17)
Legal (7940)
Liver cancer (79)
Lung cancer (341)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (325)
MASH (75)
Medical device (13433)
Medtech (13438)
Mergers & acquisitions (19661)
Metabolic disorders (708)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1941)
NextGen: Class of 2025 (6578)
Non-profit (4515)
Now hiring (40)
Obesity (374)
Opinion (211)
Ovarian cancer (82)
Pain (91)
Pancreatic cancer (89)
Parkinson's disease (151)
Partnered (21)
Patents (243)
Patient recruitment (117)
Peanut (46)
People (58047)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20974)
Phase II (29552)
Phase III (22032)
Pipeline (1356)
Policy (148)
Postmarket research (2594)
Preclinical (8892)
Press Release (64)
Prostate cancer (112)
Psychedelics (31)
Radiopharmaceuticals (259)
Rare diseases (385)
Real estate (5967)
Recruiting (65)
Regulatory (22550)
Reports (47)
Research institute (2370)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (134)
Series B (88)
Service/supplier (11)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3644)
State (2)
Stomach cancer (15)
Supply chain (68)
Tariffs (48)
The Weekly (37)
Vaccines (707)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (20)
Last 7 days (933)
Last 30 days (2994)
Last 365 days (32764)
2025 (11838)
2024 (35676)
2023 (40498)
2022 (51695)
2021 (56234)
2020 (54539)
2019 (47056)
2018 (35457)
2017 (32656)
2016 (32028)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27609)
Location
Africa (727)
Alabama (59)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38633)
Australia (6318)
California (6414)
Canada (2064)
China (546)
Colorado (271)
Connecticut (279)
Delaware (156)
Europe (84045)
Florida (947)
Georgia (213)
Idaho (58)
Illinois (556)
India (25)
Indiana (320)
Iowa (11)
Japan (174)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (929)
Massachusetts (4830)
Michigan (223)
Minnesota (406)
Mississippi (2)
Missouri (81)
Montana (29)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1791)
New Mexico (28)
New York (1806)
North Carolina (994)
North Dakota (8)
Northern California (2819)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1428)
Puerto Rico (13)
Rhode Island (33)
South America (1109)
South Carolina (25)
South Dakota (1)
Southern California (2411)
Tennessee (106)
Texas (951)
United States (24089)
Utah (188)
Virginia (151)
Washington D.C. (65)
Washington State (565)
West Virginia (3)
Wisconsin (57)
707,691 Results for "citius oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
11 min read
Press Releases
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
February 6, 2025
·
13 min read
Press Releases
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 5, 2025
·
2 min read
Press Releases
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
January 7, 2025
·
15 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 29, 2024
·
11 min read
Press Releases
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
August 13, 2024
·
9 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
November 11, 2024
·
18 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
12 min read
Press Releases
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.
August 5, 2024
·
8 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
September 5, 2024
·
14 min read
1 of 70,770
Next
